Clinical Trial Update: Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Renvela for hyperphosphatemia in chronic kidney disease patients not on dialysis in China has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• Renvela (sevelamer carbonate)

Snippet

Sponsor: Sanofi | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED | Results posted: 2020-07-28